Global Influenza Drugs Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Influenza Drugs Market Size was estimated at USD 1774.40 million in 2023 and is projected to reach USD 2156.02 million by 2029, exhibiting a CAGR of 3.30% during the forecast period.
This report provides a deep insight into the global Influenza Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Drugs market in any manner.
Global Influenza Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol-Myers Squibb]
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Market Segmentation (by Type)
Zanamivir
Oseltamivir Phosphate
Peramivir
Other Influenza Drugs
Market Segmentation (by Application)
Adults
Chidren
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Influenza Drugs Market Size was estimated at USD 1774.40 million in 2023 and is projected to reach USD 2156.02 million by 2029, exhibiting a CAGR of 3.30% during the forecast period.
This report provides a deep insight into the global Influenza Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Influenza Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Influenza Drugs market in any manner.
Global Influenza Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol-Myers Squibb]
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi Pasteur
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Market Segmentation (by Type)
Zanamivir
Oseltamivir Phosphate
Peramivir
Other Influenza Drugs
Market Segmentation (by Application)
Adults
Chidren
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Influenza Drugs Market
- Overview of the regional outlook of the Influenza Drugs Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Influenza Drugs
1.2 Key Market Segments
1.2.1 Influenza Drugs Segment by Type
1.2.2 Influenza Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Influenza Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Influenza Drugs Sales by Manufacturers (2019-2024)
3.2 Global Influenza Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Influenza Drugs Sales Sites, Area Served, Product Type
3.6 Influenza Drugs Market Competitive Situation and Trends
3.6.1 Influenza Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFLUENZA DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Influenza Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFLUENZA DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Drugs Sales Market Share by Type (2019-2024)
6.3 Global Influenza Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Influenza Drugs Price by Type (2019-2024)
7 INFLUENZA DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Drugs Market Sales by Application (2019-2024)
7.3 Global Influenza Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Influenza Drugs Sales Growth Rate by Application (2019-2024)
8 INFLUENZA DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Influenza Drugs Sales by Region
8.1.1 Global Influenza Drugs Sales by Region
8.1.2 Global Influenza Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bristol-Myers Squibb]
9.1.1 Bristol-Myers Squibb] Influenza Drugs Basic Information
9.1.2 Bristol-Myers Squibb] Influenza Drugs Product Overview
9.1.3 Bristol-Myers Squibb] Influenza Drugs Product Market Performance
9.1.4 Bristol-Myers Squibb] Business Overview
9.1.5 Bristol-Myers Squibb] Influenza Drugs SWOT Analysis
9.1.6 Bristol-Myers Squibb] Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Influenza Drugs Basic Information
9.2.2 AstraZeneca Influenza Drugs Product Overview
9.2.3 AstraZeneca Influenza Drugs Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Influenza Drugs SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Eli Lilly
9.3.1 Eli Lilly Influenza Drugs Basic Information
9.3.2 Eli Lilly Influenza Drugs Product Overview
9.3.3 Eli Lilly Influenza Drugs Product Market Performance
9.3.4 Eli Lilly Influenza Drugs SWOT Analysis
9.3.5 Eli Lilly Business Overview
9.3.6 Eli Lilly Recent Developments
9.4 Roche
9.4.1 Roche Influenza Drugs Basic Information
9.4.2 Roche Influenza Drugs Product Overview
9.4.3 Roche Influenza Drugs Product Market Performance
9.4.4 Roche Business Overview
9.4.5 Roche Recent Developments
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Influenza Drugs Basic Information
9.5.2 GlaxoSmithKline Influenza Drugs Product Overview
9.5.3 GlaxoSmithKline Influenza Drugs Product Market Performance
9.5.4 GlaxoSmithKline Business Overview
9.5.5 GlaxoSmithKline Recent Developments
9.6 Novartis
9.6.1 Novartis Influenza Drugs Basic Information
9.6.2 Novartis Influenza Drugs Product Overview
9.6.3 Novartis Influenza Drugs Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Pfizer
9.7.1 Pfizer Influenza Drugs Basic Information
9.7.2 Pfizer Influenza Drugs Product Overview
9.7.3 Pfizer Influenza Drugs Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Sanofi Pasteur
9.8.1 Sanofi Pasteur Influenza Drugs Basic Information
9.8.2 Sanofi Pasteur Influenza Drugs Product Overview
9.8.3 Sanofi Pasteur Influenza Drugs Product Market Performance
9.8.4 Sanofi Pasteur Business Overview
9.8.5 Sanofi Pasteur Recent Developments
9.9 Bayer
9.9.1 Bayer Influenza Drugs Basic Information
9.9.2 Bayer Influenza Drugs Product Overview
9.9.3 Bayer Influenza Drugs Product Market Performance
9.9.4 Bayer Business Overview
9.9.5 Bayer Recent Developments
9.10 Celgene
9.10.1 Celgene Influenza Drugs Basic Information
9.10.2 Celgene Influenza Drugs Product Overview
9.10.3 Celgene Influenza Drugs Product Market Performance
9.10.4 Celgene Business Overview
9.10.5 Celgene Recent Developments
9.11 Seqirus
9.11.1 Seqirus Influenza Drugs Basic Information
9.11.2 Seqirus Influenza Drugs Product Overview
9.11.3 Seqirus Influenza Drugs Product Market Performance
9.11.4 Seqirus Business Overview
9.11.5 Seqirus Recent Developments
9.12 Protein Sciences Corporation
9.12.1 Protein Sciences Corporation Influenza Drugs Basic Information
9.12.2 Protein Sciences Corporation Influenza Drugs Product Overview
9.12.3 Protein Sciences Corporation Influenza Drugs Product Market Performance
9.12.4 Protein Sciences Corporation Business Overview
9.12.5 Protein Sciences Corporation Recent Developments
9.13 Serum Institute of India
9.13.1 Serum Institute of India Influenza Drugs Basic Information
9.13.2 Serum Institute of India Influenza Drugs Product Overview
9.13.3 Serum Institute of India Influenza Drugs Product Market Performance
9.13.4 Serum Institute of India Business Overview
9.13.5 Serum Institute of India Recent Developments
9.14 Emergent Biosolutions
9.14.1 Emergent Biosolutions Influenza Drugs Basic Information
9.14.2 Emergent Biosolutions Influenza Drugs Product Overview
9.14.3 Emergent Biosolutions Influenza Drugs Product Market Performance
9.14.4 Emergent Biosolutions Business Overview
9.14.5 Emergent Biosolutions Recent Developments
9.15 BioCryst Pharmaceuticals
9.15.1 BioCryst Pharmaceuticals Influenza Drugs Basic Information
9.15.2 BioCryst Pharmaceuticals Influenza Drugs Product Overview
9.15.3 BioCryst Pharmaceuticals Influenza Drugs Product Market Performance
9.15.4 BioCryst Pharmaceuticals Business Overview
9.15.5 BioCryst Pharmaceuticals Recent Developments
9.16 Alvogen
9.16.1 Alvogen Influenza Drugs Basic Information
9.16.2 Alvogen Influenza Drugs Product Overview
9.16.3 Alvogen Influenza Drugs Product Market Performance
9.16.4 Alvogen Business Overview
9.16.5 Alvogen Recent Developments
10 INFLUENZA DRUGS MARKET FORECAST BY REGION
10.1 Global Influenza Drugs Market Size Forecast
10.2 Global Influenza Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Drugs Market Size Forecast by Region
10.2.4 South America Influenza Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Influenza Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Influenza Drugs by Type (2025-2030)
11.1.2 Global Influenza Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Influenza Drugs by Type (2025-2030)
11.2 Global Influenza Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Influenza Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Influenza Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Influenza Drugs
1.2 Key Market Segments
1.2.1 Influenza Drugs Segment by Type
1.2.2 Influenza Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Drugs Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Influenza Drugs Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Global Influenza Drugs Sales by Manufacturers (2019-2024)
3.2 Global Influenza Drugs Revenue Market Share by Manufacturers (2019-2024)
3.3 Influenza Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Influenza Drugs Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Influenza Drugs Sales Sites, Area Served, Product Type
3.6 Influenza Drugs Market Competitive Situation and Trends
3.6.1 Influenza Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Influenza Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 INFLUENZA DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Influenza Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 INFLUENZA DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Drugs Sales Market Share by Type (2019-2024)
6.3 Global Influenza Drugs Market Size Market Share by Type (2019-2024)
6.4 Global Influenza Drugs Price by Type (2019-2024)
7 INFLUENZA DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Drugs Market Sales by Application (2019-2024)
7.3 Global Influenza Drugs Market Size (M USD) by Application (2019-2024)
7.4 Global Influenza Drugs Sales Growth Rate by Application (2019-2024)
8 INFLUENZA DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Influenza Drugs Sales by Region
8.1.1 Global Influenza Drugs Sales by Region
8.1.2 Global Influenza Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Influenza Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Influenza Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Influenza Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Influenza Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Influenza Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bristol-Myers Squibb]
9.1.1 Bristol-Myers Squibb] Influenza Drugs Basic Information
9.1.2 Bristol-Myers Squibb] Influenza Drugs Product Overview
9.1.3 Bristol-Myers Squibb] Influenza Drugs Product Market Performance
9.1.4 Bristol-Myers Squibb] Business Overview
9.1.5 Bristol-Myers Squibb] Influenza Drugs SWOT Analysis
9.1.6 Bristol-Myers Squibb] Recent Developments
9.2 AstraZeneca
9.2.1 AstraZeneca Influenza Drugs Basic Information
9.2.2 AstraZeneca Influenza Drugs Product Overview
9.2.3 AstraZeneca Influenza Drugs Product Market Performance
9.2.4 AstraZeneca Business Overview
9.2.5 AstraZeneca Influenza Drugs SWOT Analysis
9.2.6 AstraZeneca Recent Developments
9.3 Eli Lilly
9.3.1 Eli Lilly Influenza Drugs Basic Information
9.3.2 Eli Lilly Influenza Drugs Product Overview
9.3.3 Eli Lilly Influenza Drugs Product Market Performance
9.3.4 Eli Lilly Influenza Drugs SWOT Analysis
9.3.5 Eli Lilly Business Overview
9.3.6 Eli Lilly Recent Developments
9.4 Roche
9.4.1 Roche Influenza Drugs Basic Information
9.4.2 Roche Influenza Drugs Product Overview
9.4.3 Roche Influenza Drugs Product Market Performance
9.4.4 Roche Business Overview
9.4.5 Roche Recent Developments
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Influenza Drugs Basic Information
9.5.2 GlaxoSmithKline Influenza Drugs Product Overview
9.5.3 GlaxoSmithKline Influenza Drugs Product Market Performance
9.5.4 GlaxoSmithKline Business Overview
9.5.5 GlaxoSmithKline Recent Developments
9.6 Novartis
9.6.1 Novartis Influenza Drugs Basic Information
9.6.2 Novartis Influenza Drugs Product Overview
9.6.3 Novartis Influenza Drugs Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Pfizer
9.7.1 Pfizer Influenza Drugs Basic Information
9.7.2 Pfizer Influenza Drugs Product Overview
9.7.3 Pfizer Influenza Drugs Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Sanofi Pasteur
9.8.1 Sanofi Pasteur Influenza Drugs Basic Information
9.8.2 Sanofi Pasteur Influenza Drugs Product Overview
9.8.3 Sanofi Pasteur Influenza Drugs Product Market Performance
9.8.4 Sanofi Pasteur Business Overview
9.8.5 Sanofi Pasteur Recent Developments
9.9 Bayer
9.9.1 Bayer Influenza Drugs Basic Information
9.9.2 Bayer Influenza Drugs Product Overview
9.9.3 Bayer Influenza Drugs Product Market Performance
9.9.4 Bayer Business Overview
9.9.5 Bayer Recent Developments
9.10 Celgene
9.10.1 Celgene Influenza Drugs Basic Information
9.10.2 Celgene Influenza Drugs Product Overview
9.10.3 Celgene Influenza Drugs Product Market Performance
9.10.4 Celgene Business Overview
9.10.5 Celgene Recent Developments
9.11 Seqirus
9.11.1 Seqirus Influenza Drugs Basic Information
9.11.2 Seqirus Influenza Drugs Product Overview
9.11.3 Seqirus Influenza Drugs Product Market Performance
9.11.4 Seqirus Business Overview
9.11.5 Seqirus Recent Developments
9.12 Protein Sciences Corporation
9.12.1 Protein Sciences Corporation Influenza Drugs Basic Information
9.12.2 Protein Sciences Corporation Influenza Drugs Product Overview
9.12.3 Protein Sciences Corporation Influenza Drugs Product Market Performance
9.12.4 Protein Sciences Corporation Business Overview
9.12.5 Protein Sciences Corporation Recent Developments
9.13 Serum Institute of India
9.13.1 Serum Institute of India Influenza Drugs Basic Information
9.13.2 Serum Institute of India Influenza Drugs Product Overview
9.13.3 Serum Institute of India Influenza Drugs Product Market Performance
9.13.4 Serum Institute of India Business Overview
9.13.5 Serum Institute of India Recent Developments
9.14 Emergent Biosolutions
9.14.1 Emergent Biosolutions Influenza Drugs Basic Information
9.14.2 Emergent Biosolutions Influenza Drugs Product Overview
9.14.3 Emergent Biosolutions Influenza Drugs Product Market Performance
9.14.4 Emergent Biosolutions Business Overview
9.14.5 Emergent Biosolutions Recent Developments
9.15 BioCryst Pharmaceuticals
9.15.1 BioCryst Pharmaceuticals Influenza Drugs Basic Information
9.15.2 BioCryst Pharmaceuticals Influenza Drugs Product Overview
9.15.3 BioCryst Pharmaceuticals Influenza Drugs Product Market Performance
9.15.4 BioCryst Pharmaceuticals Business Overview
9.15.5 BioCryst Pharmaceuticals Recent Developments
9.16 Alvogen
9.16.1 Alvogen Influenza Drugs Basic Information
9.16.2 Alvogen Influenza Drugs Product Overview
9.16.3 Alvogen Influenza Drugs Product Market Performance
9.16.4 Alvogen Business Overview
9.16.5 Alvogen Recent Developments
10 INFLUENZA DRUGS MARKET FORECAST BY REGION
10.1 Global Influenza Drugs Market Size Forecast
10.2 Global Influenza Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Influenza Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Influenza Drugs Market Size Forecast by Region
10.2.4 South America Influenza Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Influenza Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Influenza Drugs Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Influenza Drugs by Type (2025-2030)
11.1.2 Global Influenza Drugs Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Influenza Drugs by Type (2025-2030)
11.2 Global Influenza Drugs Market Forecast by Application (2025-2030)
11.2.1 Global Influenza Drugs Sales (Kilotons) Forecast by Application
11.2.2 Global Influenza Drugs Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Drugs Market Size Comparison by Region (M USD)
Table 5. Global Influenza Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Influenza Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Influenza Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Influenza Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs as of 2022)
Table 10. Global Market Influenza Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Influenza Drugs Sales Sites and Area Served
Table 12. Manufacturers Influenza Drugs Product Type
Table 13. Global Influenza Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Influenza Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Drugs Market Challenges
Table 22. Global Influenza Drugs Sales by Type (Kilotons)
Table 23. Global Influenza Drugs Market Size by Type (M USD)
Table 24. Global Influenza Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Influenza Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Influenza Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Influenza Drugs Market Size Share by Type (2019-2024)
Table 28. Global Influenza Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Influenza Drugs Sales (Kilotons) by Application
Table 30. Global Influenza Drugs Market Size by Application
Table 31. Global Influenza Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Influenza Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Influenza Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Influenza Drugs Market Share by Application (2019-2024)
Table 35. Global Influenza Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Influenza Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Influenza Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Influenza Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Influenza Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Influenza Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Influenza Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Influenza Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Bristol-Myers Squibb] Influenza Drugs Basic Information
Table 44. Bristol-Myers Squibb] Influenza Drugs Product Overview
Table 45. Bristol-Myers Squibb] Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bristol-Myers Squibb] Business Overview
Table 47. Bristol-Myers Squibb] Influenza Drugs SWOT Analysis
Table 48. Bristol-Myers Squibb] Recent Developments
Table 49. AstraZeneca Influenza Drugs Basic Information
Table 50. AstraZeneca Influenza Drugs Product Overview
Table 51. AstraZeneca Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Influenza Drugs SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. Eli Lilly Influenza Drugs Basic Information
Table 56. Eli Lilly Influenza Drugs Product Overview
Table 57. Eli Lilly Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Eli Lilly Influenza Drugs SWOT Analysis
Table 59. Eli Lilly Business Overview
Table 60. Eli Lilly Recent Developments
Table 61. Roche Influenza Drugs Basic Information
Table 62. Roche Influenza Drugs Product Overview
Table 63. Roche Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Roche Business Overview
Table 65. Roche Recent Developments
Table 66. GlaxoSmithKline Influenza Drugs Basic Information
Table 67. GlaxoSmithKline Influenza Drugs Product Overview
Table 68. GlaxoSmithKline Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Recent Developments
Table 71. Novartis Influenza Drugs Basic Information
Table 72. Novartis Influenza Drugs Product Overview
Table 73. Novartis Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Pfizer Influenza Drugs Basic Information
Table 77. Pfizer Influenza Drugs Product Overview
Table 78. Pfizer Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. Sanofi Pasteur Influenza Drugs Basic Information
Table 82. Sanofi Pasteur Influenza Drugs Product Overview
Table 83. Sanofi Pasteur Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sanofi Pasteur Business Overview
Table 85. Sanofi Pasteur Recent Developments
Table 86. Bayer Influenza Drugs Basic Information
Table 87. Bayer Influenza Drugs Product Overview
Table 88. Bayer Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Bayer Business Overview
Table 90. Bayer Recent Developments
Table 91. Celgene Influenza Drugs Basic Information
Table 92. Celgene Influenza Drugs Product Overview
Table 93. Celgene Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Celgene Business Overview
Table 95. Celgene Recent Developments
Table 96. Seqirus Influenza Drugs Basic Information
Table 97. Seqirus Influenza Drugs Product Overview
Table 98. Seqirus Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Seqirus Business Overview
Table 100. Seqirus Recent Developments
Table 101. Protein Sciences Corporation Influenza Drugs Basic Information
Table 102. Protein Sciences Corporation Influenza Drugs Product Overview
Table 103. Protein Sciences Corporation Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Protein Sciences Corporation Business Overview
Table 105. Protein Sciences Corporation Recent Developments
Table 106. Serum Institute of India Influenza Drugs Basic Information
Table 107. Serum Institute of India Influenza Drugs Product Overview
Table 108. Serum Institute of India Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Serum Institute of India Business Overview
Table 110. Serum Institute of India Recent Developments
Table 111. Emergent Biosolutions Influenza Drugs Basic Information
Table 112. Emergent Biosolutions Influenza Drugs Product Overview
Table 113. Emergent Biosolutions Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Emergent Biosolutions Business Overview
Table 115. Emergent Biosolutions Recent Developments
Table 116. BioCryst Pharmaceuticals Influenza Drugs Basic Information
Table 117. BioCryst Pharmaceuticals Influenza Drugs Product Overview
Table 118. BioCryst Pharmaceuticals Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. BioCryst Pharmaceuticals Business Overview
Table 120. BioCryst Pharmaceuticals Recent Developments
Table 121. Alvogen Influenza Drugs Basic Information
Table 122. Alvogen Influenza Drugs Product Overview
Table 123. Alvogen Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Alvogen Business Overview
Table 125. Alvogen Recent Developments
Table 126. Global Influenza Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Influenza Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Influenza Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Influenza Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Influenza Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Influenza Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Influenza Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Influenza Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Influenza Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Influenza Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Influenza Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Influenza Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Influenza Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Influenza Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Influenza Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Influenza Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Influenza Drugs Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Drugs Market Size Comparison by Region (M USD)
Table 5. Global Influenza Drugs Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Influenza Drugs Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Influenza Drugs Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Influenza Drugs Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs as of 2022)
Table 10. Global Market Influenza Drugs Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Influenza Drugs Sales Sites and Area Served
Table 12. Manufacturers Influenza Drugs Product Type
Table 13. Global Influenza Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Influenza Drugs
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Influenza Drugs Market Challenges
Table 22. Global Influenza Drugs Sales by Type (Kilotons)
Table 23. Global Influenza Drugs Market Size by Type (M USD)
Table 24. Global Influenza Drugs Sales (Kilotons) by Type (2019-2024)
Table 25. Global Influenza Drugs Sales Market Share by Type (2019-2024)
Table 26. Global Influenza Drugs Market Size (M USD) by Type (2019-2024)
Table 27. Global Influenza Drugs Market Size Share by Type (2019-2024)
Table 28. Global Influenza Drugs Price (USD/Ton) by Type (2019-2024)
Table 29. Global Influenza Drugs Sales (Kilotons) by Application
Table 30. Global Influenza Drugs Market Size by Application
Table 31. Global Influenza Drugs Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Influenza Drugs Sales Market Share by Application (2019-2024)
Table 33. Global Influenza Drugs Sales by Application (2019-2024) & (M USD)
Table 34. Global Influenza Drugs Market Share by Application (2019-2024)
Table 35. Global Influenza Drugs Sales Growth Rate by Application (2019-2024)
Table 36. Global Influenza Drugs Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Influenza Drugs Sales Market Share by Region (2019-2024)
Table 38. North America Influenza Drugs Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Influenza Drugs Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Influenza Drugs Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Influenza Drugs Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Influenza Drugs Sales by Region (2019-2024) & (Kilotons)
Table 43. Bristol-Myers Squibb] Influenza Drugs Basic Information
Table 44. Bristol-Myers Squibb] Influenza Drugs Product Overview
Table 45. Bristol-Myers Squibb] Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bristol-Myers Squibb] Business Overview
Table 47. Bristol-Myers Squibb] Influenza Drugs SWOT Analysis
Table 48. Bristol-Myers Squibb] Recent Developments
Table 49. AstraZeneca Influenza Drugs Basic Information
Table 50. AstraZeneca Influenza Drugs Product Overview
Table 51. AstraZeneca Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. AstraZeneca Business Overview
Table 53. AstraZeneca Influenza Drugs SWOT Analysis
Table 54. AstraZeneca Recent Developments
Table 55. Eli Lilly Influenza Drugs Basic Information
Table 56. Eli Lilly Influenza Drugs Product Overview
Table 57. Eli Lilly Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Eli Lilly Influenza Drugs SWOT Analysis
Table 59. Eli Lilly Business Overview
Table 60. Eli Lilly Recent Developments
Table 61. Roche Influenza Drugs Basic Information
Table 62. Roche Influenza Drugs Product Overview
Table 63. Roche Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Roche Business Overview
Table 65. Roche Recent Developments
Table 66. GlaxoSmithKline Influenza Drugs Basic Information
Table 67. GlaxoSmithKline Influenza Drugs Product Overview
Table 68. GlaxoSmithKline Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Recent Developments
Table 71. Novartis Influenza Drugs Basic Information
Table 72. Novartis Influenza Drugs Product Overview
Table 73. Novartis Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Pfizer Influenza Drugs Basic Information
Table 77. Pfizer Influenza Drugs Product Overview
Table 78. Pfizer Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. Sanofi Pasteur Influenza Drugs Basic Information
Table 82. Sanofi Pasteur Influenza Drugs Product Overview
Table 83. Sanofi Pasteur Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Sanofi Pasteur Business Overview
Table 85. Sanofi Pasteur Recent Developments
Table 86. Bayer Influenza Drugs Basic Information
Table 87. Bayer Influenza Drugs Product Overview
Table 88. Bayer Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Bayer Business Overview
Table 90. Bayer Recent Developments
Table 91. Celgene Influenza Drugs Basic Information
Table 92. Celgene Influenza Drugs Product Overview
Table 93. Celgene Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Celgene Business Overview
Table 95. Celgene Recent Developments
Table 96. Seqirus Influenza Drugs Basic Information
Table 97. Seqirus Influenza Drugs Product Overview
Table 98. Seqirus Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Seqirus Business Overview
Table 100. Seqirus Recent Developments
Table 101. Protein Sciences Corporation Influenza Drugs Basic Information
Table 102. Protein Sciences Corporation Influenza Drugs Product Overview
Table 103. Protein Sciences Corporation Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Protein Sciences Corporation Business Overview
Table 105. Protein Sciences Corporation Recent Developments
Table 106. Serum Institute of India Influenza Drugs Basic Information
Table 107. Serum Institute of India Influenza Drugs Product Overview
Table 108. Serum Institute of India Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Serum Institute of India Business Overview
Table 110. Serum Institute of India Recent Developments
Table 111. Emergent Biosolutions Influenza Drugs Basic Information
Table 112. Emergent Biosolutions Influenza Drugs Product Overview
Table 113. Emergent Biosolutions Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Emergent Biosolutions Business Overview
Table 115. Emergent Biosolutions Recent Developments
Table 116. BioCryst Pharmaceuticals Influenza Drugs Basic Information
Table 117. BioCryst Pharmaceuticals Influenza Drugs Product Overview
Table 118. BioCryst Pharmaceuticals Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. BioCryst Pharmaceuticals Business Overview
Table 120. BioCryst Pharmaceuticals Recent Developments
Table 121. Alvogen Influenza Drugs Basic Information
Table 122. Alvogen Influenza Drugs Product Overview
Table 123. Alvogen Influenza Drugs Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Alvogen Business Overview
Table 125. Alvogen Recent Developments
Table 126. Global Influenza Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Influenza Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Influenza Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Influenza Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Influenza Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Influenza Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Influenza Drugs Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Influenza Drugs Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Influenza Drugs Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Influenza Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Influenza Drugs Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Influenza Drugs Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Influenza Drugs Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Influenza Drugs Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Influenza Drugs Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Influenza Drugs Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Influenza Drugs Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Drugs Market Size (M USD), 2019-2030
Figure 5. Global Influenza Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Influenza Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Drugs Market Size by Country (M USD)
Figure 11. Influenza Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Influenza Drugs Revenue Share by Manufacturers in 2023
Figure 13. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Influenza Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Influenza Drugs Market Share by Type
Figure 18. Sales Market Share of Influenza Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Influenza Drugs by Type in 2023
Figure 20. Market Size Share of Influenza Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Influenza Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Influenza Drugs Market Share by Application
Figure 24. Global Influenza Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Influenza Drugs Sales Market Share by Application in 2023
Figure 26. Global Influenza Drugs Market Share by Application (2019-2024)
Figure 27. Global Influenza Drugs Market Share by Application in 2023
Figure 28. Global Influenza Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Influenza Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Influenza Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Influenza Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Influenza Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Influenza Drugs Sales Market Share by Country in 2023
Figure 37. Germany Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Influenza Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Influenza Drugs Sales Market Share by Region in 2023
Figure 44. China Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Influenza Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Influenza Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Influenza Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Influenza Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Influenza Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Influenza Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Influenza Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Influenza Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Influenza Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Influenza Drugs Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Influenza Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Drugs Market Size (M USD), 2019-2030
Figure 5. Global Influenza Drugs Market Size (M USD) (2019-2030)
Figure 6. Global Influenza Drugs Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Drugs Market Size by Country (M USD)
Figure 11. Influenza Drugs Sales Share by Manufacturers in 2023
Figure 12. Global Influenza Drugs Revenue Share by Manufacturers in 2023
Figure 13. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Influenza Drugs Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Influenza Drugs Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Influenza Drugs Market Share by Type
Figure 18. Sales Market Share of Influenza Drugs by Type (2019-2024)
Figure 19. Sales Market Share of Influenza Drugs by Type in 2023
Figure 20. Market Size Share of Influenza Drugs by Type (2019-2024)
Figure 21. Market Size Market Share of Influenza Drugs by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Influenza Drugs Market Share by Application
Figure 24. Global Influenza Drugs Sales Market Share by Application (2019-2024)
Figure 25. Global Influenza Drugs Sales Market Share by Application in 2023
Figure 26. Global Influenza Drugs Market Share by Application (2019-2024)
Figure 27. Global Influenza Drugs Market Share by Application in 2023
Figure 28. Global Influenza Drugs Sales Growth Rate by Application (2019-2024)
Figure 29. Global Influenza Drugs Sales Market Share by Region (2019-2024)
Figure 30. North America Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Influenza Drugs Sales Market Share by Country in 2023
Figure 32. U.S. Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Influenza Drugs Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Influenza Drugs Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Influenza Drugs Sales Market Share by Country in 2023
Figure 37. Germany Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Influenza Drugs Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Influenza Drugs Sales Market Share by Region in 2023
Figure 44. China Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Influenza Drugs Sales and Growth Rate (Kilotons)
Figure 50. South America Influenza Drugs Sales Market Share by Country in 2023
Figure 51. Brazil Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Influenza Drugs Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Influenza Drugs Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Influenza Drugs Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Influenza Drugs Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Influenza Drugs Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Influenza Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Influenza Drugs Market Share Forecast by Type (2025-2030)
Figure 65. Global Influenza Drugs Sales Forecast by Application (2025-2030)
Figure 66. Global Influenza Drugs Market Share Forecast by Application (2025-2030)
